6416011000001107: Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Quinine bisulphate\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing Cinchona alkaloid\Product containing quinine\Quinine bisulphate\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing Cinchona alkaloid\Product containing quinine\Product containing only quinine (medicinal product)\Product containing only quinine in oral dose form (medicinal product form)\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing Cinchona alkaloid\Product containing quinine\Product containing quinine in oral dose form (medicinal product form)\Product containing only quinine in oral dose form (medicinal product form)\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antiparasitic agent (product)\Medicinal product acting as antiprotozoal agent (product)\Medicinal product acting as antimalarial agent (product)\Product containing quinine\Quinine bisulphate\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antiparasitic agent (product)\Medicinal product acting as antiprotozoal agent (product)\Medicinal product acting as antimalarial agent (product)\Product containing quinine\Product containing only quinine (medicinal product)\Product containing only quinine in oral dose form (medicinal product form)\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antiparasitic agent (product)\Medicinal product acting as antiprotozoal agent (product)\Medicinal product acting as antimalarial agent (product)\Product containing quinine\Product containing quinine in oral dose form (medicinal product form)\Product containing only quinine in oral dose form (medicinal product form)\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing quinine in oral dose form (medicinal product form)\Product containing only quinine in oral dose form (medicinal product form)\Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet\Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1851541000001112 Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1851551000001110 Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Is a	Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has active ingredient	Quinine bisulfate	false	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has specific active ingredient	Quinine bisulfate	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) 500 tablet	Is pack of	False	Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) 500 tablet	Has AMP	True	Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1851541000001112	Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1851551000001110	Quinine bisulfate 300mg tablets sugar coated (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module